Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy

Dagmar Hartung, Masayoshi Sarai, Artiom Petrov, Frank Kolodgie, Navneet Narula, Johan Verjans, Renu Virmani, Chris Reutelingsperger, Leo Hofstra, Jagat Narula

研究成果: Article

64 引用 (Scopus)

抄録

Although apoptosis within atherosclerotic plaques is associated with plaque vulnerability and rupture, the role of inhibition of the apoptotic process is not clear. We evaluated the impact of dietary modification and statin therapy (measures known to favorably influence outcomes in coronary disease) on the incidence of apoptosis in experimental atherosclerotic lesions. Methods: A total of 30 animals were studied; 1 group of 6 animals served as the controls (group 1), and the remaining 24 animals were subjected to balloon de-endothelialization of the abdominal aorta and a high-cholesterol diet. These atherosclerotic animals were randomized as follows: high-cholesterol diet for 4 mo (n = 6; untreated atherosclerotic group [group 2]), high-cholesterol diet for 3 mo and normal chow diet for 1 mo (n = 6; diet withdrawal group [group 3]), and high-cholesterol diet for 4 mo and simvastatin orally every day of the last month (n = 6; statin therapy group [group 4]). 99mTc-Annexin A5 was used for noninvasive detection of apoptosis in groups 1-4. The remaining 6 rabbits on a high-cholesterol diet for 4 mo were studied with radiolabeled mutant annexin A5 (n = 6; nonspecific control group [group 5]). Quantitative annexin A5 uptake in the abdominal aorta was determined and compared with the histologic and immunohistochemical characteristics of the atherosclerotic lesions. Results: Maximum annexin A5 uptake (mean ± SD, 0.051 ± 0.009 percentage injected dose per gram [%ID/g] of tissue) was observed in the untreated atherosclerotic animals. The uptake was substantially reduced in the diet withdrawal (0.03 ± 0.006 %ID/g; P < 0.0001) and statin therapy (0.03 ± 0.006 %ID/g; P < 0.0001) groups. The plaques in the untreated high-cholesterol group demonstrated advanced atherosclerotic lesions. On the other hand, the diet withdrawal and statin therapy groups showed histologic characteristics of stabilization, including the resolution of macrophage infiltration and an increase in smooth muscle cell content. There was a marked reduction in the apoptosis of macrophages. No significant uptake of annexin A5 or mutant annexin A5 was seen in rabbits on the normal chow diet or atherosclerotic rabbits, respectively. Conclusion: Dietary modification and statin therapy in atherosclerosis lead to a reduction in apoptosis and contribute to plaque stabilization. It can be hypothesized that a reduction in apoptosis is a favorable process in atherosclerotic disease.

元の言語English
ページ(範囲)2051-2056
ページ数6
ジャーナルJournal of Nuclear Medicine
46
発行部数12
出版物ステータスPublished - 01-12-2005

Fingerprint

Diet Therapy
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Atherosclerotic Plaques
Apoptosis
Diet
Annexin A5
Cholesterol
Therapeutics
Abdominal Aorta
Group Psychotherapy
Rabbits
Macrophages
Control Groups
Simvastatin
Smooth Muscle Myocytes
Coronary Disease
Rupture
Atherosclerosis

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

これを引用

Hartung, D., Sarai, M., Petrov, A., Kolodgie, F., Narula, N., Verjans, J., ... Narula, J. (2005). Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy. Journal of Nuclear Medicine, 46(12), 2051-2056.
Hartung, Dagmar ; Sarai, Masayoshi ; Petrov, Artiom ; Kolodgie, Frank ; Narula, Navneet ; Verjans, Johan ; Virmani, Renu ; Reutelingsperger, Chris ; Hofstra, Leo ; Narula, Jagat. / Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy. :: Journal of Nuclear Medicine. 2005 ; 巻 46, 番号 12. pp. 2051-2056.
@article{195ca736ed5c48729eb89cb35d5e391c,
title = "Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy",
abstract = "Although apoptosis within atherosclerotic plaques is associated with plaque vulnerability and rupture, the role of inhibition of the apoptotic process is not clear. We evaluated the impact of dietary modification and statin therapy (measures known to favorably influence outcomes in coronary disease) on the incidence of apoptosis in experimental atherosclerotic lesions. Methods: A total of 30 animals were studied; 1 group of 6 animals served as the controls (group 1), and the remaining 24 animals were subjected to balloon de-endothelialization of the abdominal aorta and a high-cholesterol diet. These atherosclerotic animals were randomized as follows: high-cholesterol diet for 4 mo (n = 6; untreated atherosclerotic group [group 2]), high-cholesterol diet for 3 mo and normal chow diet for 1 mo (n = 6; diet withdrawal group [group 3]), and high-cholesterol diet for 4 mo and simvastatin orally every day of the last month (n = 6; statin therapy group [group 4]). 99mTc-Annexin A5 was used for noninvasive detection of apoptosis in groups 1-4. The remaining 6 rabbits on a high-cholesterol diet for 4 mo were studied with radiolabeled mutant annexin A5 (n = 6; nonspecific control group [group 5]). Quantitative annexin A5 uptake in the abdominal aorta was determined and compared with the histologic and immunohistochemical characteristics of the atherosclerotic lesions. Results: Maximum annexin A5 uptake (mean ± SD, 0.051 ± 0.009 percentage injected dose per gram [{\%}ID/g] of tissue) was observed in the untreated atherosclerotic animals. The uptake was substantially reduced in the diet withdrawal (0.03 ± 0.006 {\%}ID/g; P < 0.0001) and statin therapy (0.03 ± 0.006 {\%}ID/g; P < 0.0001) groups. The plaques in the untreated high-cholesterol group demonstrated advanced atherosclerotic lesions. On the other hand, the diet withdrawal and statin therapy groups showed histologic characteristics of stabilization, including the resolution of macrophage infiltration and an increase in smooth muscle cell content. There was a marked reduction in the apoptosis of macrophages. No significant uptake of annexin A5 or mutant annexin A5 was seen in rabbits on the normal chow diet or atherosclerotic rabbits, respectively. Conclusion: Dietary modification and statin therapy in atherosclerosis lead to a reduction in apoptosis and contribute to plaque stabilization. It can be hypothesized that a reduction in apoptosis is a favorable process in atherosclerotic disease.",
author = "Dagmar Hartung and Masayoshi Sarai and Artiom Petrov and Frank Kolodgie and Navneet Narula and Johan Verjans and Renu Virmani and Chris Reutelingsperger and Leo Hofstra and Jagat Narula",
year = "2005",
month = "12",
day = "1",
language = "English",
volume = "46",
pages = "2051--2056",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "12",

}

Hartung, D, Sarai, M, Petrov, A, Kolodgie, F, Narula, N, Verjans, J, Virmani, R, Reutelingsperger, C, Hofstra, L & Narula, J 2005, 'Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy', Journal of Nuclear Medicine, 巻. 46, 番号 12, pp. 2051-2056.

Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy. / Hartung, Dagmar; Sarai, Masayoshi; Petrov, Artiom; Kolodgie, Frank; Narula, Navneet; Verjans, Johan; Virmani, Renu; Reutelingsperger, Chris; Hofstra, Leo; Narula, Jagat.

:: Journal of Nuclear Medicine, 巻 46, 番号 12, 01.12.2005, p. 2051-2056.

研究成果: Article

TY - JOUR

T1 - Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy

AU - Hartung, Dagmar

AU - Sarai, Masayoshi

AU - Petrov, Artiom

AU - Kolodgie, Frank

AU - Narula, Navneet

AU - Verjans, Johan

AU - Virmani, Renu

AU - Reutelingsperger, Chris

AU - Hofstra, Leo

AU - Narula, Jagat

PY - 2005/12/1

Y1 - 2005/12/1

N2 - Although apoptosis within atherosclerotic plaques is associated with plaque vulnerability and rupture, the role of inhibition of the apoptotic process is not clear. We evaluated the impact of dietary modification and statin therapy (measures known to favorably influence outcomes in coronary disease) on the incidence of apoptosis in experimental atherosclerotic lesions. Methods: A total of 30 animals were studied; 1 group of 6 animals served as the controls (group 1), and the remaining 24 animals were subjected to balloon de-endothelialization of the abdominal aorta and a high-cholesterol diet. These atherosclerotic animals were randomized as follows: high-cholesterol diet for 4 mo (n = 6; untreated atherosclerotic group [group 2]), high-cholesterol diet for 3 mo and normal chow diet for 1 mo (n = 6; diet withdrawal group [group 3]), and high-cholesterol diet for 4 mo and simvastatin orally every day of the last month (n = 6; statin therapy group [group 4]). 99mTc-Annexin A5 was used for noninvasive detection of apoptosis in groups 1-4. The remaining 6 rabbits on a high-cholesterol diet for 4 mo were studied with radiolabeled mutant annexin A5 (n = 6; nonspecific control group [group 5]). Quantitative annexin A5 uptake in the abdominal aorta was determined and compared with the histologic and immunohistochemical characteristics of the atherosclerotic lesions. Results: Maximum annexin A5 uptake (mean ± SD, 0.051 ± 0.009 percentage injected dose per gram [%ID/g] of tissue) was observed in the untreated atherosclerotic animals. The uptake was substantially reduced in the diet withdrawal (0.03 ± 0.006 %ID/g; P < 0.0001) and statin therapy (0.03 ± 0.006 %ID/g; P < 0.0001) groups. The plaques in the untreated high-cholesterol group demonstrated advanced atherosclerotic lesions. On the other hand, the diet withdrawal and statin therapy groups showed histologic characteristics of stabilization, including the resolution of macrophage infiltration and an increase in smooth muscle cell content. There was a marked reduction in the apoptosis of macrophages. No significant uptake of annexin A5 or mutant annexin A5 was seen in rabbits on the normal chow diet or atherosclerotic rabbits, respectively. Conclusion: Dietary modification and statin therapy in atherosclerosis lead to a reduction in apoptosis and contribute to plaque stabilization. It can be hypothesized that a reduction in apoptosis is a favorable process in atherosclerotic disease.

AB - Although apoptosis within atherosclerotic plaques is associated with plaque vulnerability and rupture, the role of inhibition of the apoptotic process is not clear. We evaluated the impact of dietary modification and statin therapy (measures known to favorably influence outcomes in coronary disease) on the incidence of apoptosis in experimental atherosclerotic lesions. Methods: A total of 30 animals were studied; 1 group of 6 animals served as the controls (group 1), and the remaining 24 animals were subjected to balloon de-endothelialization of the abdominal aorta and a high-cholesterol diet. These atherosclerotic animals were randomized as follows: high-cholesterol diet for 4 mo (n = 6; untreated atherosclerotic group [group 2]), high-cholesterol diet for 3 mo and normal chow diet for 1 mo (n = 6; diet withdrawal group [group 3]), and high-cholesterol diet for 4 mo and simvastatin orally every day of the last month (n = 6; statin therapy group [group 4]). 99mTc-Annexin A5 was used for noninvasive detection of apoptosis in groups 1-4. The remaining 6 rabbits on a high-cholesterol diet for 4 mo were studied with radiolabeled mutant annexin A5 (n = 6; nonspecific control group [group 5]). Quantitative annexin A5 uptake in the abdominal aorta was determined and compared with the histologic and immunohistochemical characteristics of the atherosclerotic lesions. Results: Maximum annexin A5 uptake (mean ± SD, 0.051 ± 0.009 percentage injected dose per gram [%ID/g] of tissue) was observed in the untreated atherosclerotic animals. The uptake was substantially reduced in the diet withdrawal (0.03 ± 0.006 %ID/g; P < 0.0001) and statin therapy (0.03 ± 0.006 %ID/g; P < 0.0001) groups. The plaques in the untreated high-cholesterol group demonstrated advanced atherosclerotic lesions. On the other hand, the diet withdrawal and statin therapy groups showed histologic characteristics of stabilization, including the resolution of macrophage infiltration and an increase in smooth muscle cell content. There was a marked reduction in the apoptosis of macrophages. No significant uptake of annexin A5 or mutant annexin A5 was seen in rabbits on the normal chow diet or atherosclerotic rabbits, respectively. Conclusion: Dietary modification and statin therapy in atherosclerosis lead to a reduction in apoptosis and contribute to plaque stabilization. It can be hypothesized that a reduction in apoptosis is a favorable process in atherosclerotic disease.

UR - http://www.scopus.com/inward/record.url?scp=33644874497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644874497&partnerID=8YFLogxK

M3 - Article

C2 - 16330569

AN - SCOPUS:33644874497

VL - 46

SP - 2051

EP - 2056

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 12

ER -

Hartung D, Sarai M, Petrov A, Kolodgie F, Narula N, Verjans J その他. Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy. Journal of Nuclear Medicine. 2005 12 1;46(12):2051-2056.